4//SEC Filing
Stuart Iain 4
Accession 0001209191-24-000469
CIK 0001566044other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:21 PM ET
Size
10.0 KB
Accession
0001209191-24-000469
Insider Transaction Report
Form 4
Stuart Iain
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2024-01-01+62,500→ 134,055 total - Tax Payment
Common Stock
2024-01-02$2.28/sh−157$358→ 133,898 total - Award
Stock Option (right to buy)
2024-01-01+62,500→ 62,500 totalExercise: $2.33Exp: 2033-12-31→ Common Stock (62,500 underlying)
Footnotes (4)
- [F1]Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
- [F3]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
- [F4]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727756
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:21 PM ET
- Size
- 10.0 KB